Jasper Ridge Partners’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-16,000
Closed -$381K 98
2014
Q3
$381K Hold
16,000
0.03% 84
2014
Q2
$370K Hold
16,000
0.03% 99
2014
Q1
$365K Hold
16,000
0.02% 97
2013
Q4
$296K Hold
16,000
0.02% 104
2013
Q3
$271K Hold
16,000
0.02% 104
2013
Q2
$248K Buy
+16,000
New +$266K 0.01% 102

Other funds holding NVO

Jasper Ridge Partners's NVO Position: Q4 2014 in Review

Jasper Ridge Partners sold out of Novo Nordisk (NVO) in Q4 2014, closing a stake of 16,000 shares — an estimated $381K sold.

Jasper Ridge Partners first reported a position in NVO in Q2 2013 and held it in 6 quarters. The position peaked at $381K in Q3 2014. 501 funds tracked by Wall St. Rank hold NVO as of Q4 2014.

  • Jasper Ridge Partners reported no remaining Novo Nordisk position as of Q4 2014 after selling out during the quarter.
  • Jasper Ridge Partners sold 16,000 Novo Nordisk shares in Q4 2014, an estimated $381K.
  • Jasper Ridge Partners first reported a position in Novo Nordisk in Q2 2013 and held it in 6 quarters.
  • Jasper Ridge Partners's Novo Nordisk position peaked at $381K in Q3 2014.
  • 501 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2014.

Based on Jasper Ridge Partners's 13F filing for Q4 2014, filed 12 Feb 2015.